Posts

Showing posts with the label SAVA

New SAVA fansite SAVA-AD.COM

I submitted an article for https://www.sava-ad.com/ Please check it out. The peeps there are such good writers. I really believe in this company and their Alzheimer's drug. My grandma passed away from this. It's deeply personal. Looking at the amazing data, this drug probably could have helped her.

Calling All SAVAge Apes!

This is a guest post by Internal_Ad_1091. Listen up! Im about to present a once-in-a-generation opportunity to 75x your money**.** Too much, or too good to be true? Im being conservative. Hear me out. First, I shall Flex: I am an MD and a Professor. To spell out the obvious, I have insight into what matters in the medical world. Many pure researchers lack this (cough cough Elisabeth Bik). In addition, As medical school faculty, If I can't figure it out, I know who to ask. I started investing (profitably) before most of you were born. Why flex? To make it abundantly clear, my opinion on biotech investing matters just a little. With that said, once more, listen up! The Pickle: You youngins haven't noticed, but Alzheimer's is the 6th leading cause of death in the US. Currently, Alzheimer's is an epidemic. The kicker is, there is NO effective treatment. The FDA needed a drug so desperately they approved Aduhelm. This drug has significant adverse events. The ri...

$SAVA and $GME Correlation and what it means

Image
 They seem to have a strong correlation today and during other down days. First image is from today and second image is a Dr. Michael Burry tweet. The theory is that big hedge funds holding mostly big tech mega caps like AAPL, GOOG, FB, MSFT, AMZN are shorting speculative stocks as hedges. We are spending all our time discussing the science of simufilam and the merits of the citizen's petition but there are other big factors driving the price action. This implies that we can use the opportunity to create short squeezes. We hold the bags now but this stock is going to the moon. The short stock availability went from over 850k shares to now 0 shares very quickly today. This is a potential short squeeze setup. I don't know how long it would take or how high the stock needs to be pushed, but the potential is certainly there on a day of good news. 9/8/2021 Update : No short squeeze yet but it is looking more likely as the short interest continues to increase.

Should you buy SAVA stock?

Image
  Buying shares of early stage biotech companies is one of the ways that cash-strapped investors can plant the seeds of massive growth. These companies have the potential to be 100x or 1000x the initial investment. What better way than to look into a cure for Alzheimer’s? I got into SAVA (Cassava Biosciences, lead drug simufilam) at $47 when I was reading an article on Seeking Alpha about the promising company. Given my background treating Alzheimer’s patients, I knew I could do my own homework on the data. They have groundbreaking 9 month data on their new Alzheimer's drug, far better than any drug before it. At 9 months, instead of a 4 point decline as is typical in disease progression, it's a 3 point improvement. This 7 point difference is a very big deal for both cognition and ability to live independently. If even results half this good are replicated in a Phase 3 trial, the FDA would approve it easily. For me, seeing the data, the stock is already de-risked. The stock is ...